Drug intelligence / Profile preview

QUALI

Development stage: Unknown
Modality: Small Molecules
Administration: Oral

Overview

QUALI is an investigational drug administered as a capsule with a biphasic delivery system. It is currently undergoing Phase II clinical trials for the treatment of insomnia disorder, aiming to improve sleep quality and related metrics such as total sleep time, sleep efficiency, and sleep latency.

Beyond the preview

Go deeper on QUALI.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on QUALI.

Explore the full profile